NASDAQ:GBT
Global Blood Therapeutics, Inc.
- Stock
Last Close
68.48
04/10 20:00
Volume Today
3.28M
Avg: -
PE Ratio
−27.41
PFCF: -
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | ||
|---|---|---|---|---|---|---|---|---|---|---|
revenue | 2.11M - | 123.80M 5,773.01% | 194.75M 57.31% | |||||||
cost of revenue | 48K - | 1.99M 4,037.50% | 3.32M 66.97% | |||||||
gross profit | 2.06M - | 121.82M 5,813.45% | 191.43M 57.15% | |||||||
selling and marketing expenses | ||||||||||
general and administrative expenses | 2.31M - | 3.85M 66.96% | 9.67M 150.87% | 21.91M 126.61% | 31.44M 43.45% | 51.44M 63.61% | 117.09M 127.64% | |||
selling general and administrative expenses | 2.31M - | 3.85M 66.96% | 9.67M 150.87% | 21.91M 126.61% | 31.44M 43.45% | 51.44M 63.61% | 117.09M 127.64% | 210.85M 80.08% | 266.99M 26.62% | |
research and development expenses | 12.86M - | 16.32M 26.99% | 36.66M 124.56% | 61.21M 66.99% | 87.81M 43.45% | 131.31M 49.54% | 174.56M 32.94% | 155.12M 11.13% | 212.13M 36.75% | |
other expenses | 65K - | 210.85M - | ||||||||
cost and expenses | 15.66M - | 20.51M 30.95% | 46.39M 126.19% | 83.13M 79.18% | 119.25M 43.45% | 182.74M 53.25% | 291.69M 59.62% | 367.96M 26.15% | 482.44M 31.11% | |
operating expenses | 15.16M - | 20.18M 33.07% | 46.39M 129.91% | 83.13M 79.18% | 119.25M 43.45% | 182.74M 53.25% | 291.64M 59.59% | 365.97M 25.49% | 479.12M 30.92% | |
interest expense | 9.81M - | 15.47M 57.68% | ||||||||
ebitda | -17.58M - | -20.14M 14.55% | -45.49M 125.84% | -81.23M 78.59% | -115.37M 42.02% | -169.59M 47.00% | -256.83M 51.45% | -226.92M 11.65% | -278.53M 22.74% | |
operating income | -15.66M - | -20.51M 30.95% | -46.39M 126.19% | -83.13M 79.18% | -119.25M 43.45% | -182.74M 53.25% | -281.28M 53.92% | -243.17M 13.55% | -287.15M 18.08% | |
depreciation and amortization | 534K - | 666K 24.72% | 873K 31.08% | 1.24M 41.47% | 1.66M 34.25% | 4.61M 177.86% | 9.93M 115.58% | 10.82M 8.97% | 8.62M 20.39% | |
total other income expenses net | -2.45M - | -296K 87.93% | 33K 111.15% | 659K 1,896.97% | 2.22M 237.03% | 8.55M 284.92% | 14.52M 69.81% | -4.38M 130.18% | -15.47M 253.05% | |
income before tax | -18.12M - | -20.81M 14.85% | -46.36M 122.81% | -82.47M 77.89% | -117.02M 41.90% | -174.19M 48.85% | -266.77M 53.14% | -247.55M 7.20% | -302.61M 22.24% | |
income tax expense | -2.45M - | -296K 87.93% | 33K 111.15% | 659K 1,896.97% | 2.22M 237.03% | 8.55M 284.92% | 14.52M 69.81% | 5.43M 62.61% | 477K 91.21% | |
net income | -18.12M - | -20.81M 14.85% | -46.36M 122.81% | -82.47M 77.89% | -117.02M 41.90% | -174.19M 48.85% | -266.77M 53.14% | -247.55M 7.20% | -303.09M 22.43% | |
weighted average shs out | 21.80M - | 13.76M 36.87% | 12.81M 6.94% | 33.21M 159.30% | 42.32M 27.45% | 51.15M 20.86% | 58.32M 14.02% | 61.33M 5.17% | 62.93M 2.59% | |
weighted average shs out dil | 21.80M - | 13.76M 36.87% | 12.81M 6.94% | 33.21M 159.30% | 42.32M 27.45% | 51.15M 20.86% | 58.32M 14.02% | 61.33M 5.17% | 62.93M 2.59% | |
eps | -0.83 - | -1.51 81.93% | -3.62 139.74% | -2.48 31.49% | -2.76 11.29% | -3.41 23.55% | -4.57 34.02% | -4.04 11.60% | -4.82 19.31% | |
epsdiluted | -0.83 - | -1.51 81.93% | -3.62 139.74% | -2.48 31.49% | -2.76 11.29% | -3.41 23.55% | -4.57 34.02% | -4.04 11.60% | -4.82 19.31% |
All numbers in USD (except ratios and percentages)